Results 81 to 90 of about 4,127 (170)

Locoregional Therapies for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease

Biomedicines
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide with an average five-year survival rate in the US of 19.6%.
Stephen Susman, Breanna Santoso, Mina S. Makary   +2 more
doaj   +1 more source

Yttrium-90 radioembolization for treatment of anaplastic meningioma liver metastases

Radiology Case Reports
Meningiomas are the most common primary intracranial neoplasm. The WHO classification, focusing on histomorphologic and molecular features, distinguishes WHO grade -1, -2, and -3 tumors.
Mohammad-Kasim Fassia, Arsalan Haghdel, Fred Pelzman, Rajiv Magge, Susan Pannullo, Benjamin Liechty, Theodore H. Schwartz, Jonathan P.S. Knisely, Jana Ivanidze, Brian Currie   +9 more
doaj   +1 more source

Role of Transarterial Radioembolization in Management of HCC

Transarterial Radioembolization (TARE) is an emerging therapy for the management of hepatocellular carcinoma (HCC). Radioactive Y90 can be loaded onto glass or resin microparticles for intra-arterial selective internal radiation therapy. TARE is a multistage procedure requiring a mapping procedure and a treatment procedure.
Wali Badar, Ali Husnain, John Fung, Osman Ahmed   +3 more
openaire   +1 more source

Comparative Evaluation of Intraarterial Therapy Methods for Hepatocellular Cancer

Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Aim: to compare various methods of intraarterial therapy for hepatocellular carcinoma (HCC) in terms of survival, adverse events, and cost-effectiveness.Key points.
A. P. Petrosyan, V. V. Kucherov, Yu. A. Emelyanova, A. D. Kaprin, S. A. Ivanov, L. O. Petrov, N. A. Falaleeva, A. G. Isaeva, A. S. Dikova, A. T. Stekhova, E. A. Volicheva   +10 more
doaj   +1 more source

Survival and Dosimetry in Advanced Hepatocellular Carcinoma with Tumor Sizes Up to 20 cm: A High Tumor Volume Institutional Cohort

Cerrahpaşa Medical Journal
Objective: Transarterial radioembolization with yttrium-90 (Y-90 TARE) is a well-established locoregional therapy for hepatocellular carcinoma (HCC) in patients who are not candidates for transarterial chemoembolization (TACE); however, its clinical ...
Seçkin Bilgiç, Uğurcan Sayılı, Sait Sağer, Kerim Sönmezoğlu   +3 more
doaj   +1 more source

Transarterial Chemoembolization vs Yttrium-90 Transarterial Radioembolization [PDF]

Gastroenterology, 2017
Lance L, Stein, Madeline C, Tully, Aravind, Arepally   +2 more
openaire   +2 more sources

Stereotactic body radiation therapy is associated with improved overall survival compared to chemoradiation or radioembolization in the treatment of unresectable intrahepatic cholangiocarcinoma

Clinical and Translational Radiation Oncology, 2019
Background: Intrahepatic cholangiocarcinoma (ICC) is a highly lethal malignancy. For patients with locally advanced, unresectable disease, numerous liver-directed therapy options exist, including chemoradiation (CRT), stereotactic body radiation therapy (
Nikhil T. Sebastian, Yubo Tan, Eric D. Miller, Terence M. Williams, Dayssy Alexandra Diaz   +4 more
doaj   +1 more source

The role of radiological interventions in hepatocellular carcinoma before liver transplantation: a surgical perspective

Frontiers in Surgery
Liver transplantation (LT) remains the gold standard treatment for patients with unresectable hepatocellular carcinoma (HCC) within or, in select cases, beyond the Milan criteria. However, with the increasing complexity of HCC management and the scarcity
Altan Alim, Derek DuBay
doaj   +1 more source

Health Outcomes and Resource Consumption Analysis of Radioembolization with Y90 Glass Microspheres (TARE-Y90) Versus Transarterial Chemoembolization with Irinotecan (DEBIRI) in Patients with Liver Metastases from Colorectal Cancer in Spain

Diagnostics
Background: The present study aims to investigate the superiority of TARE-Y90 in the treatment of liver metastases from colorectal cancer in comparison to DEBIRI and perform a parallel resource consumption study to demonstrate a possible favorable cost ...
Juan José Ciampi-Dopazo, Gonzalo Ruiz Villaverde, Juan José Espejo, Raúl García Marcos, Daniel Pérez Enguix, Serena Pisoni, José J. Martínez-Rodrigo, Pablo Navarro Vergara, Pedro Pardo Moreno, Antonio Rodríguez-Fernández   +9 more
doaj   +1 more source

Current role of chemoembolization in the treatment of hepatocellular carcinoma

Nowotwory
Hepatocellular carcinoma (HCC) accounts for 75% to 85% of primary liver cancers. Recent years have shown a significant increase in the incidence of HCC in Europe and the United States.
Rafał Kidziński, Grzegorz Kade, Krzysztof Pyra   +2 more
doaj   +1 more source